Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 20, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 6 July 2026 - 15:50

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 20, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/enhertu

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters